Systematic Reviews
Copyright ©The Author(s) 2023.
World J Cardiol. Jun 26, 2023; 15(6): 309-323
Published online Jun 26, 2023. doi: 10.4330/wjc.v15.i6.309
Table 2 Baseline characteristics of the included subjects
Ref.
Study group
Age, years (SD)
Male, n (%)
Hypertension, n (%)
Diabetes mellitus, n (%)
Hyperlipidemia, n (%)
Smoking, n (%)
Daoulah et al[15]Pandemic period STEMI55.4 (11.8)454 (90.8)229 (46.7)257 (52.1)190 (38.9)213 (43)
Pre-pandemic period STEMI56.5 (12.8)1123 (87.5)599 (47.6)632 (50.4)450 (35.8)318 (41.6)
Leng et al[16]Pandemic period STEMI63.13 (13.6)131 (79.9)N/AN/AN/AN/A
Pre-pandemic period STEMI62.21 (13.14)178 (73.9)N/AN/AN/AN/A
Song et al[17]Pandemic period STEMI61.6 (13.1)59 (80.82)43 (58.9)16 (21.9)39 (53.4)36 (49.3)
Pre-pandemic period STEMI60.6 (13.9)68 (71.57)56 (59)22 (23.2)51 (53.7)55 (57.9)
Wang et al[18]Pandemic period STEMI59.29 (11.46)33 (89.18)20 (54.05)6 (16.21)13 (35.13)37 (100)
Pre-pandemic period STEMI55.49 (11.89)35 (85.36)18 (43.90)5 (12.19)15 (36.58)31 (75.60)
Wu et al[19]Pandemic period STEMI65.1 (13.6)1181 (73.81)581 (36.31)309 (19.31)368 (23)450 (28.12)
Pre-pandemic period STEMI65.76 (13.44)11263 (71.98)6060 (38.73)3005 (19.20)3645 (23.29)4704 (30.06)
Xiang et al[20]Pandemic period STEMI61.59 (13.10)7986 (75.94)N/AN/AN/AN/A
Pre-pandemic period STEMI62.86 (12.33)11019 (75.29)N/AN/AN/AN/A
Zhang et al[21]Pandemic period STEMIN/AN/AN/AN/AN/AN/A
Pre-pandemic period STEMIN/AN/AN/AN/AN/AN/A
Huang et al[22]Pandemic period STEMI61 25 (80.6)16 (51.6)8 (25.8)7 (22.6)18 (58.1)
Pre-pandemic period STEMI6025 (80.6)18 (58.1)6 (19.4)8 (25.8)20 (64.5)
Erol et al[23]Pandemic period STEMI59 (13)552 (77.63)221 (45.56)151 (31.13)108 (22.26)248 (50.30)
Pre-pandemic period STEMI60 (14)387 (79.79)273 (38.39)201 (28.27)67 (9.4)401 (56.39)
Mesnier et al[24]Pandemic period STEMI63.4 (12.5)357 (74)116 (24.11)35 (7.27)N/A96 (19.95)
Pre-pandemic period STEMI64.4 (13.6)509 (74)139 (20.26)55 (8.01)N/A131 (19.09)
Balghith[25]Pandemic period STEMI57.2 (12.6)83 (90.21)44 (54.32)45 (48.91)36 (39.13)41 (44.56)
Pre-pandemic period STEMI51.3 (11.5)81 (100)38 (41.3)41 (44.56)31 (33.69)35 (38.04)
Clifford et al[26]Pandemic period STEMI65 (12)169 (71)99 (51.29)55 (28.49)86 (44.55)53 (27.46)
Pre-pandemic period STEMI64 (13)135 (70)123 (51.68)54 (22.68)99 (41.5)93 (39.07)
Rodríguez-Leor et al[27]Pandemic period STEMI63.1 (12.5)786 (78.4)520 (51.9)226 (22.6)466 (46.7)442 (44.6)
Pre-pandemic period STEMI63.7 (13.2)1023 (78.4)647 (50)224 (25.2)592 (45.8)581 (45.7)
Calvão et al[28]Pandemic period STEMI63.3 (12.7)56 (78.9)49 (69.01)23 (32.39)38 (53.52)40 (56.33)
Pre-pandemic period STEMI65.7 (12.8)60 (75)48 (60)26 (32.5)49 (57.5)39 (48.75)

  • Citation: Khedr A, Hennawi HA, Khan MK, Elbanna M, Jama AB, Proskuriakova E, Mushtaq H, Mir M, Boike S, Rauf I, Eissa A, Urtecho M, Koritala T, Jain N, Goyal L, Surani S, Khan SA. Effect of fibrinolytic therapy on ST-elevation myocardial infarction clinical outcomes during the COVID-19 pandemic: A systematic review and meta-analysis. World J Cardiol 2023; 15(6): 309-323
  • URL: https://www.wjgnet.com/1949-8462/full/v15/i6/309.htm
  • DOI: https://dx.doi.org/10.4330/wjc.v15.i6.309